EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Sundry Debtors History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹88 Cr | ₹100 Cr | ₹76 Cr | ₹69 Cr | ₹51 Cr |
What is the latest Sundry Debtors ratio of EVEREST ORGANICS ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹88 Cr |
| Mar2024 | ₹100 Cr |
| Mar2023 | ₹76 Cr |
| Mar2022 | ₹69 Cr |
| Mar2021 | ₹51 Cr |
How is Sundry Debtors of EVEREST ORGANICS Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹88 Cr | -11.64 | |
| Mar2024 | ₹100 Cr | 31.11 | |
| Mar2023 | ₹76 Cr | 11.33 | |
| Mar2022 | ₹69 Cr | 35.46 | |
| Mar2021 | ₹51 Cr | - | |
Compare Sundry Debtors of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹239.7 Cr | 2.8% | -14.2% | -12.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,083.0 Cr | -1% | -7% | -1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,971.0 Cr | 5% | -2.7% | 15.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,660.0 Cr | 3.2% | -6.2% | 29.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,686.0 Cr | 2.3% | -8.1% | 13.5% | Stock Analytics | |
| CIPLA | ₹99,086.7 Cr | 0.9% | -7.8% | -12.5% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | 2.8% |
-14.2% |
-12.8% |
| SENSEX | 4.7% |
-0.1% |
3.6% |
You may also like the below Video Courses